From: Terje Rod-Larsen < Sent: Saturday, March 9, 2013 11:46 PM To: 'Jeevacation@gmail.cont Subject: Re: Fwd: Polio - update - specific asks: My staff are working on Nigeria and Pakistan. The other stuff is at the center of what IPI could do. From: Jeffrey Epstein <jeevacation@gmailcom> To: Terje Rod-Larsen Sent: Sat Mar 09 18:20:12 2013 Subject: Fwd: Polio - update - specific asks: Forwarded messa e From: Boris Nikolic Date: Sat, Mar 9, 2013 at 7:18 PM Subject: Polio - update - specific asks: To: "Jeffrey Epstein (jeevacation@gmail.com <mailto:jeevacation@gmail.com> )" <jeevacation@gmail.com <mailtojeevacation@gmail.com» Sorry that I was not enough specific in my previous email. Attached document should help in bringing up to speed with our Polio efforts in Nigeria and Pakistan. It also provides an update on what is happening and who we are already working with. Specific Questions are: 1) Any advice re dealing with the violence in Nigeria and Pakistan? Who is perceived as influential in these problematic areas of Nigeria and Pakistan? 2) Who could help in mediating peace and advocating for polio vaccination? 3) Who in the middle east to approach to have them speak out in favor of the Polio campaign. EFTA_R1_00069221 EFTA01763270 4) How/who can assess whether the Taliban or Boko Harem can be ok with polio eradication and if so how we avoid conflict Please let me know if you need any more information. Thank you! Boris The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeevacation@gmail.com> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved 2 EFTA_R1_00069222 EFTA01763271